The relationship between periodontal disease and a number of systemic conditions such as cardiovascular disease, type 2 diabetes and rheumatoid arthritis is already well established. Researchers at the University of Birmingham are developing a rapid test to identify the presence of periodontal disease in hopes of improving the overall health of patients with these comorbidities.
The device is being developed by Professor Tim Albrecht of the university's School of Chemistry, along with Dr Melissa Grant of the university's School of Dentistry. It consists of a specialized probe and detector that allow measuring certain protein-based biomarkers that indicate both the presence and progression of periodontal disease. This panel of biomarkers was discovered and validated in a study published in July 2022 in the Journal of Clinical Periodontology.
"We believe that the device we are prototyping will be the first dental probe capable of identifying periodontal disease in this way," Albrecht said in a press release. "It will detect periodontitis quickly and easily in a variety of healthcare settings, opening up opportunities for follow-up and early intervention in patients with comorbid diseases, who would benefit most from rapid treatment of periodontitis."
"The ability to detect and profile disease biomarkers in real time will allow monitoring disease severity and, in particular, the transition between milder and more severe forms of gum disease," Grant said. This will benefit not only dental health, but also cost reduction and recruitment of patients whose lives can be saved by periodontal treatment in the long term."
The researchers have recently received funding from the UK's Engineering and Physical Sciences Research Council, and plan to develop a prototype of this device within a year. In the long term, they hope to develop a probe small enough to insert into the interdental spaces that will allow dentists and other healthcare professionals to collect saliva and gingival crevicular fluid and measure the progression of periodontal disease.
This article was originally published in Odontologia33.
Products 13 December 2024
Pusan National University Researchers Discover Potential Biomarkers for Peri-Implantitis
The number of people receiving dental implants is increasing annually as more individuals become aware of the advantages of replacing missing teeth.
Oral Hygiene & Prevention 16 August 2023
Salivary cortisol, anxiety in Canadian dentists during COVID-19
The dental profession has endured unprecedented disruption amid COVID-19. Novel stressors have included a high risk of occupational exposure to COVID-19, financial losses, and stricter infection...
Dental materials 15 August 2023
Each day, humans produce approximately 0.5 through 1.5 liters of saliva, a biofluid that is rich in biological omic constituents. Our lack of understanding how omic biomarkers migrate from diseased...
Periodontology 07 June 2023
Peri-implant diseases diagnosis, prognosis and dental implant monitoring
The diagnosis of peri-implantar and periodontal relies mainly on a set of clinical measures and the evaluation of radiographic images. However, these clinical settings alone are not sufficient to...
Oral pathology 01 February 2023
By Arianna Bianchi
In a study published in Dentomaxillofacial Radiology in May 2020, the authors evaluated the effectiveness of ultra-high frequency ultrasound on assessing oral mucosa.
The Sino-Dental 2026 will take place from June 9, 2026 to June 12, 2026 in Beijing, China, offering dental professionals a focused environment for continuing education, clinical updates and industry...
Edra Professional Books 10 May 2026
3D Radiology in Dentistry: A Practical Reference for CBCT Integration in Clinical Practice
3D Radiology in Dentistry is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.
News 08 May 2026
Maria Gutierrez in Yorba Linda, California, has added the DEXIS Orthopantomograph OP 3D EX cone beam computed tomography (CBCT) system to its practice.
News 08 May 2026
35-year healthcare veteran who scaled dental and Medicaid programs to over $1 billion in revenue joins as LightSpun enters critical growth phase on the heels of NationsBenefits and